Article ; Online: Gender differences in prevalence and clinical correlates of anxiety in first-episode and drug-naïve patients with major depressive disorder comorbid with metabolic syndrome.
2024 Volume 24, Issue 1, Page(s) 156
Abstract: Background: Although gender differences in major depressive disorder (MDD) have been widely reported, there has not been much focus on gender differences in comorbidity. In patients with MDD and comorbid metabolic syndrome (Mets), the goal of this study ...
Abstract | Background: Although gender differences in major depressive disorder (MDD) have been widely reported, there has not been much focus on gender differences in comorbidity. In patients with MDD and comorbid metabolic syndrome (Mets), the goal of this study was to investigate potential gender differences in the prevalence and clinical correlates of concomitant anxiety. Methods: Seven hundred and ninety-four first-episode and drug-naïve patients (FEDN) patients with MDD and comorbid Mets were recruited. For each patient, sociodemographic data, thyroid function indicators, and Mets parameters were acquired. Each participant completed the 14-item Hamilton Assessment Scale for Anxiety (HAMA) and the 17-item Hamilton Assessment Scale for Depression (HAMD). Results: There were no gender differences in the prevalence of anxiety in patients with MDD and comorbid Mets. Female patients with MDD had a shorter duration of illness. Correlation analysis showed that HAMD score, TSH, TgAb, and TPOAb were associated with anxiety prevalence in female patients, whereas anxiety onset in male patients was only associated with TSH, TgAb, and TPOAb levels. In addition, multiple logistic regression analysis showed that TSH and TgAb predicted anxiety in male patients, whereas HAMD score and age of onset significantly predicted anxiety in female patients. Limitations: Cross-sectional design and no control for anxiety-related factors. Conclusions: Our study showed no gender differences in the prevalence of anxiety in patients with MDD and comorbid Mets. HAMD score was associated with anxiety in female patients, whereas TSH, TgAb, and TPOAb were associated with anxiety in male patients. |
---|---|
MeSH term(s) | Humans ; Male ; Female ; Depressive Disorder, Major/complications ; Depressive Disorder, Major/epidemiology ; Metabolic Syndrome/complications ; Metabolic Syndrome/epidemiology ; Prevalence ; Cross-Sectional Studies ; Sex Factors ; Anxiety/complications ; Anxiety/epidemiology ; Comorbidity ; Thyrotropin |
Chemical Substances | Thyrotropin (9002-71-5) |
Language | English |
Publishing date | 2024-02-22 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 2050438-X |
ISSN | 1471-244X ; 1471-244X |
ISSN (online) | 1471-244X |
ISSN | 1471-244X |
DOI | 10.1186/s12888-024-05574-w |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.